These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 31794487

  • 21. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
    Takeuchi A, Tsuchiya H, Ishii T, Nishida Y, Abe S, Matsumine A, Kawai A, Yoshimura K, Ueda T.
    BMC Musculoskelet Disord; 2016 Jul 22; 17():306. PubMed ID: 27448567
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610.
    Urakawa H, Nagano A, Machida R, Tanaka K, Kataoka T, Sekino Y, Nishida Y, Takahashi M, Kunisada T, Kawano M, Yoshida Y, Takagi T, Sato K, Hiruma T, Hatano H, Tsukushi S, Sakamoto A, Akisue T, Hiraoka K, Ozaki T.
    Jpn J Clin Oncol; 2022 Sep 18; 52(9):1021-1028. PubMed ID: 35472141
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
    Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS.
    Eur J Cancer; 2016 May 18; 59():1-12. PubMed ID: 26990281
    [Abstract] [Full Text] [Related]

  • 27. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
    Al Farii H, McChesney G, Patel SS, Rhines LD, Lewis VO, Bird JE.
    Spine J; 2024 Jun 18; 24(6):1056-1064. PubMed ID: 38301904
    [Abstract] [Full Text] [Related]

  • 28. Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone.
    Puri A, Gulia A, Hegde P, Verma V, Rekhi B.
    Bone Joint J; 2019 Feb 18; 101-B(2):170-177. PubMed ID: 30700112
    [Abstract] [Full Text] [Related]

  • 29. Preoperative denosumab treatment in patients with giant cell bone tumors in limbs: A retrospective study using propensity score matching.
    Huang Y, Xu M, Wang B, Zhao Z, Lin T, Huang G, Yin J, Xie X, Shen J, Zou C.
    Cancer Med; 2023 Jun 18; 12(11):12041-12049. PubMed ID: 37212474
    [Abstract] [Full Text] [Related]

  • 30. Preoperative Denosumab plus Surgery in the Management of Giant Cell Tumor of Bone: A Comprehensive Narrative Literature Review.
    Abu-Zaid A, Alaqaili SI, Ahmad SO, Bin Hazzaa I, Alharbi H.
    Gulf J Oncolog; 2019 May 18; 1(30):67-75. PubMed ID: 31242985
    [Abstract] [Full Text] [Related]

  • 31. Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius.
    Li Z, Deng Z, Yang Y, Gao D, Zhang Q, Niu X, Liu W.
    J Orthop Surg Res; 2024 Sep 28; 19(1):607. PubMed ID: 39342379
    [Abstract] [Full Text] [Related]

  • 32. Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature.
    Luengo-Alonso G, Mellado-Romero M, Shemesh S, Ramos-Pascua L, Pretell-Mazzini J.
    Arch Orthop Trauma Surg; 2019 Oct 28; 139(10):1339-1349. PubMed ID: 30877429
    [Abstract] [Full Text] [Related]

  • 33. How safe and effective is denosumab for bone giant cell tumour?
    Errani C, Tsukamoto S, Mavrogenis AF.
    Int Orthop; 2017 Nov 28; 41(11):2397-2400. PubMed ID: 28646421
    [Abstract] [Full Text] [Related]

  • 34. Current concepts in the treatment of giant cell tumour of bone.
    van der Heijden L, Dijkstra S, van de Sande M, Gelderblom H.
    Curr Opin Oncol; 2020 Jul 28; 32(4):332-338. PubMed ID: 32541321
    [Abstract] [Full Text] [Related]

  • 35. Effect evaluation of denosumab combined with curettage and bone cement reconstruction in the treatment of recurrent giant cell tumor of bone around the knee joint.
    Duan DK, Zhang GC, Sun BJ, Ma TX, Zhao M.
    Eur Rev Med Pharmacol Sci; 2023 Jun 28; 27(11):5039-5052. PubMed ID: 37318478
    [Abstract] [Full Text] [Related]

  • 36. The Role of Denosumab for Surgical Outcomes in Patients with Giant Cell Tumour of Bone: A Systematic Review.
    Gupta A, Durocher-Allen L, Popovic S, Tozer R, Yao X, Ghert M.
    Curr Oncol; 2021 Mar 22; 28(2):1302-1313. PubMed ID: 33809979
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Current Concepts in the Treatment of Giant Cell Tumor of Bone: An Update.
    Tsukamoto S, Mavrogenis AF, Masunaga T, Honoki K, Fujii H, Kido A, Tanaka Y, Errani C.
    Curr Oncol; 2024 Apr 08; 31(4):2112-2132. PubMed ID: 38668060
    [Abstract] [Full Text] [Related]

  • 39. Role of denosumab before resection and reconstruction in giant cell tumors of bone: a single-centered retrospective cohort study.
    Sahito B, Ali SME, Kumar D, Kumar J, Hussain N, Lakho T.
    Eur J Orthop Surg Traumatol; 2022 Apr 08; 32(3):567-574. PubMed ID: 34050817
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.